Why would you check for late luteal (LL) phase?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Checking for late luteal (LL) phase is crucial in women with acute hepatic porphyrias (AHP) to identify and prevent cyclic attacks related to the menstrual cycle, which typically occur during the luteal phase when progesterone levels are highest. These cyclic attacks can be prevented by recognizing and removing exacerbating factors, using a gonadotropin-releasing-hormone (GnRH) analogue, switching to a low-dose hormonal contraceptive, or administering prophylactic hemin infusions 1. Measuring serum progesterone at the onset of symptoms is useful for identifying luteal phase and potentially progesterone-induced attacks. Some key points to consider when checking for late luteal phase include:

  • Cyclic attacks in AHP are often related to the menstrual cycle, specifically the luteal phase
  • Progesterone levels are typically highest during the luteal phase, which can trigger attacks
  • GnRH analogues can be used to prevent ovulation and corpus luteum formation, thereby preventing cyclic attacks
  • Low-dose hormonal contraceptives may also be effective in preventing cyclic attacks
  • Prophylactic hemin infusions can be used to prevent recurrent attacks, including those related to the menstrual cycle 1. It is essential to individualize management and consider the patient's specific needs and circumstances when checking for late luteal phase and preventing cyclic attacks in AHP.

From the Research

Checking for Late Luteal (LL) Phase

There are no research papers provided to assist in answering this question, as the studies available are related to chronic kidney disease, diabetic nephropathy, and the role of angiotensin receptor blockers, but do not mention the late luteal phase.

  • The studies provided focus on the diagnosis, management, and treatment of chronic kidney disease and diabetic nephropathy, as discussed in 2, 3, 4, 5, 6.
  • These studies do not provide any information on the late luteal phase or its significance in medical diagnosis or treatment.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.